PSA Levels by Age: What Is Normal for Black Men and What to Do

There is no single normal PSA. In the Prostate Cancer Prevention Trial, men whose PSA never rose above 4.0 ng/mL still had cancer on biopsy 15.2 percent of the time, and the rate climbed with every step of PSA, from 6.6 percent at 0.5 or below to 26.9 percent at 3.1 to 4.0 (Thompson et al., NEJM 2004). For a Black man the question is not whether the number is under a cutoff. It is where the number sits for your age and which way it is moving. About 1 in 6 Black men will be diagnosed with prostate cancer and 1 in 35 will die of it (American Cancer Society, 2025).

The trial biopsied 2,950 men aged 62 to 91 whose PSA had never exceeded 4.0. Cancer was present in 449, and at 3.1 to 4.0 a quarter of the cancers were Gleason 7 or higher (Thompson et al., 2004). A clinician who says "3.8, so it is normal" is reading the test wrong. Roughly one man in four at that level has cancer on biopsy.

PSA rises with age and prostate size. In 1993 a Mayo Clinic team measured PSA in 471 healthy men aged 40 to 79 in Olmsted County, Minnesota, and proposed the 95th-percentile ranges most labs still print (Oesterling et al., JAMA 1993). In 1996, urologists at Walter Reed, noting that those ranges had been derived from white populations, measured PSA in 1,673 Black men with no evidence of prostate cancer and 411 with the disease. Applying the traditional ranges to Black men at 95 percent specificity would have missed 41 percent of the cancers, so they published ranges for Black men set at 95 percent sensitivity instead (Morgan et al., NEJM 1996).

The Prostate Cancer Foundation panel reviewed 264 studies and published screening guidelines for Black men in the United States in 2024: Black men who choose screening should obtain a baseline PSA between ages 40 and 45, and, depending on the value and health status, annual screening should be strongly considered. Its modeling found this could cut prostate cancer deaths in Black men by roughly 30 percent without substantially increasing overdiagnosis (Garraway et al., NEJM Evidence 2024).

The American Urological Association agrees. Statement 5 of the AUA/SUO guideline (published 2023, amended 2026) is a strong recommendation to offer screening at age 40 to 45 for people at increased risk, with Black race named first. Statement 6 sets the interval at every 2 to 4 years for ages 50 to 69, and Statement 7 lets your clinician adjust it to your PSA, risk, age, and health (Wei et al., J Urol 2023). The USPSTF, 2018 gives grade C for ages 55 to 69 and grade D after 70, and states it was not able to make a separate recommendation for African American men. If a clinician cites it to decline a PSA at 45, the reply is that both guidelines above set 40 to 45.

A 2019 study measured stored baseline PSA from 197 Black men in the Southern Community Cohort later diagnosed with prostate cancer and 569 matched controls, aged 40 to 64 at enrollment. Median PSA among the controls was 0.72 ng/mL at 40 to 49, 0.80 at 50 to 54, 0.94 at 55 to 59, and 1.03 at 60 to 64; the 90th percentiles were 1.68, 1.85, 2.73, and 3.33. The finding that matters: 95 percent of later cancers and 97 percent of aggressive cancers occurred in men whose baseline was above the median for their age (Preston et al., European Urology 2019).

• At or below your age median: risk over the next decade is low; a 2 to 4 year interval is reasonable.
• Between the median and the 90th percentile: regular screening at the shorter end of the interval.
• Above the 90th percentile: the group the PCF panel means by annual screening. Ask for it by name.

• An enlarged prostate (BPH) and inflammation. In 148 men with PSA above 4.0 and repeatedly negative biopsies, gland size and inflammation were the main drivers (Nadler et al., J Urol 1995). If you have urinary symptoms, read our guide to BPH in Black men.
• Ejaculation. PSA rose in 87 percent of men, by a mean of 41 percent at one hour, and persisted up to 48 hours. Abstain for 48 hours before the draw (Tchetgen et al., Urology 1996).
• A rectal exam. No clinically important PSA change in men with PSA under 10 (Crawford et al., JAMA 1992).
• Cycling. An hour of cycling raised PSA by a mean of 8.8 percent in a randomized study, clinically irrelevant except in two outliers (Lunacek et al., The Prostate 2022).
• Finasteride or dutasteride. The FDA prescribing information for Proscar (revised March 2026) states finasteride reduces PSA by approximately 50 percent within six months, that values should be doubled for comparison with normal ranges, and that any confirmed rise from your lowest value on the drug may signal cancer even if still in the normal range. The factor reaches 2.5 by year seven (Etzioni et al., J Urol 2005). Make sure your chart says you take it.

A single elevated PSA should not go straight to biopsy. AUA Statement 3 says to repeat the PSA before any biomarker, imaging, or biopsy.

Wait a few weeks, abstain from ejaculation for 48 hours, and repeat.

In a 773-man trial of men with a PSA of 4.0 to 10.0 and a normal rectal exam, a cutoff of 25 percent free PSA or lower detected 95 percent of cancers while avoiding 20 percent of unnecessary biopsies (Catalona et al., JAMA 1998).

PSA divided by prostate volume corrects for a large benign gland. In a database of 2,512 men, biopsying only men with a suspicious MRI or a density above 0.15 avoided 14.7 percent of biopsies while missing 1.7 percent of clinically significant cancers (Falagario et al., European Urology Oncology 2021).

In the PRECISION trial, 500 men were randomized to MRI first (biopsy only if the scan showed a target) or standard biopsy. In the MRI group, 28 percent skipped biopsy. MRI-targeted biopsy found clinically significant cancer in 38 percent of men versus 26 percent, and 13 percentage points fewer insignificant cancers, the ones that lead to overtreatment (Kasivisvanathan et al., NEJM 2018). AUA Statement 13 endorses MRI before the first biopsy.

If you are a Black man aged 40 to 45 who has never had a PSA, ask for one at your next visit and name the guideline (PCF 2024, AUA Statement 5). Ask for the actual number, not "normal," and write it down with the date. If you need a urologist, find a Black urologist in our directory. For what a biopsy and a diagnosis involve, read prostate cancer in Black men and our prostate cancer condition page.